Danay Areli

Nephrologist at Hospital Rio Hortega, Valladolid, Spain.

[Renal Path Labs @RenalPathLabs]

Only once in a lifetime, one gets to see SLE with amyloid (SAA+) and it’s good to know that it is really rare..

#RareRenalCases #RenalBiopsy #AskRenal #PathTwitter #NephTwitter #RenalPathology #SLEwithAmyloid #RenalPathLabs

[GlomCon Ibero-LatinoAmérica @GlomConILA]

No te pierdas este sábado el seminario:

☞ Biopsia renal en escenarios complejos 💉

🗓️27/Jul/24
🕘9 am CDMX
👨🏻‍⚕️Dr. Bernardo Moguel 🇲🇽@bernardo_moguel
👨🏻‍⚕️Dr. Omar Sánchez 🇲🇽@Omar_SnchezV
👨🏻‍⚕️Dr. Alejandro García🇲🇽@Alexgr23

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConILA #MeGusta

[GlomCon Ibero-LatinoAmérica @GlomConILA]

Anunciamos el lanzamiento 🚀 del #GlomConILA fellowship de enfermedades glomerulares en español con el apoyo de @SLANH_

Stay tuned!

[Nefro_Tweets @Doctor_Stewie]

#MedTwitter #MedX #nephrology
Enfermedad autoinmune propia de riñón 🫘☝🏼- Glomerulopatía Membranosa ✍🏼

🔸Tx según riesgo de progresión 👀👇🏼
🔸Niveles de Ab anti-PLA2R permitiría guiar tx incluso 🚫 biopsia ✍🏼
🔸Resumen tx actuales-nuevos👇🏼🔝

Rojas-Rivera et al. KI Reports. 2023

[Jasmine Sethi @JasmineNephro]

✅Prophylactic anticoagulation in nephrotic syndrome

🅰️Hypoalbuminemia (<2) with one of following

🎯Proteinuria >10gm/day
🎯BMI> 35
🎯Heart 💔 failure
🎯Genetic predisposed for thrombosis
🎯/Recent abdominal surgery

@goKDIGO @ISNkidneycare

[Sanjeev Sethi @SethiRenalPath]

This is a great review on mechanisms, pathophysiology, aging, assessment of the kidney biopsy, importance in clinical trials, and finally the therapeutic approaches to renal fibrosis.

From inflammation to renal fibrosis: A one-way road in autoimmunity? https://t.co/3qcjyafLzP

[KDIGO @goKDIGO]

We are pleased to announce the publication of the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis, published today in the March issue of Supplement to Kidney International, with an Executive Summary in the main pages of the journal.

Read the news release: https://t.co/ewZokps7wF

Read the guideline in Kidney International: https://t.co/M9Y1QBeS6s

Visit the KDIGO ANCA Vasculitis Website: https://t.co/oBR5IPukpe

Developed under the stewardship of Co-Chairs Brad Rovin, MD (US) and Jürgen Floege, MD (DE), this guideline is an update to the ANCA Vasculitis chapter of the KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.

"The ANCA Vasculitis Guideline includes significant updates aimed at enhancing clinical decision-making, integrating new treatments with established clinical practices," stated Dr. Floege. "We anticipate that the comprehensive research, clinical perspectives, and collaborative expertise reflected in this guideline will contribute to better outcomes for individuals grappling with this complex condition."

"We are excited to release the KDIGO 2024 ANCA Vasculitis Guideline, which offers new guidance for managing the intricacies of ANCA vasculitis treatment, particularly with the emergence of innovative therapies," said Dr. Rovin. "We are better equipped than ever to tailor interventions, optimize patient care, and strive towards improved outcomes for people with ANCA-associated vasculitis."

KDIGO thanks the Guideline Work Group for their dedication and expertise and the Evidence Review Team from Brown University School of Public Health for their comprehensive work on this guideline.

#ANCA #vasculitis #AAV #glomerular

[Roberto Alcazar @ralcazara]

En #RevistaNefrologia se revisan las enfermedades renales que cursan con hipomagnesemia. https://t.co/IU6Kr1L8Mo - La calcemia y la calciuria claves en el diagnóstico diferencial @SENefrologia @SOMANEorg #Nefro_8_01

[Andreas Kronbichler @AKronbichler]

🚨 After 3 1/2 years of work, I am very proud to share our most recent review published today in @TheLancet, together with my amazing colleagues @IMBajema @AnnetteBruchfe1 and Drs Gianna Mastroianni Kirsztajn and John Stone, focusing on AAV. https://t.co/337tRkgVZ1

[Roger Rodby @NephRodby]

How many time do I have to tell you, you don't need to dialyze after IV contrast.

[Edoardo Melilli @EdoardoMelilli]

@NephRodby @VelezNephHepato @thisis_drgsp @NephJC @hswapnil Avaco-pain 😂😂😂😂😂😂😂

[Jasmine Sethi @JasmineNephro]

🫘Two drugs frequently used by Nephrologist 🤷‍♀️that can lead to this🦷 ⤵️

✅Cyclosporine

✅Calcium channel blocker - Amlodipine

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Things We Do for No Reason: Obtaining urine culture in older adults with delirium without signs or symptoms of urinary tract infection #idxposts #TWDFNR

[Sourabh Sharma @iamnephrologist]

💥There is more to #Finerenone & Figure of Five‼️

🔥Finerenone Pentad

🔆Selection Pentad
👉Five points of inclusion
👉Five points of exclusion
👉Five points regardless

🔆Monitoring Pentad

🔆Outcome Pentad

#NephPearls #FOAMed #MedEd #MedTwitter #diabetes #kidney

[Joel M. Topf, MD FACP @kidney_boy]

In today's grand rounds I covered the CONVINCE Trial of hemodiafiltration versus high flux hemodialysis.

I figured I better explain what hemodiafiltration is. This is what I came up with.

[@Hipertension_semfyc_MAPA_HTA @HTA_semfyc_MAPA]

Standars of care Diabetes 2024
https://t.co/jAReeffjin
Así recomiendan manejo de HTA
@SEHLELHA140_90
@josegdonaire
@TGijonConde

[Roberto Alcazar @ralcazara]

¿Hay que corregir la hipernatremia lentamente? Este amplio observacional retrospectivo sugiere que NO. Peor supervivencia a 30 días si corrección < 0,5 mEq/l/h. https://t.co/vnZ2VPKv58 - Interesante. ¡Ojo! No extrapolable a la hiponatremia. @SOMANEorg @SENefrologia #Nefro_8_01

[Roger Rodby @NephRodby]

1) Today's @Rush_Nephrology biopsy conference was dedicated to Ed Lewis. I gave a short tribute to this amazing man.

[ASN Publications @asnpublications]

The benefits of SGLT2 inhibitors in patients with CKD have been well established in major clinical trials. This Perspective examines if SGLT2 inhibitors are effective & safe in patients with severe CKD, dialysis, or kidney transplantation https://t.co/xL3Y0owyOc

@StefanPBerger

[Jasmine Sethi @JasmineNephro]

☝️Answer is VEXAS

hemat 🤝rheumat

1️⃣V-vacuolated myeloid/erthroid lineage in marrow-macrocytic anemia/neutropenia/marrow failure

2️⃣E-Mutation in UBA1-lack of cytoplasmic E1

3️⃣X linked-Only 🙋‍♂️

4️⃣A Autoinflmmation-RP/chondroitis/polymyalgia/pleural effusions

5️⃣S-Somatic